Careers

Diversity

With 17 offices, from New York to Los Angeles and Seattle to Orlando, we live and work in communities all over the U.S., collaborating across locations, disciplines and even borders. Our experienced, highly ranked lawyers serve businesses wherever they are and wherever they want to go.

Offices

About Us

Pages

Professionals

Thought leadership: blogs, podcasts, videos, publications, events and news

Insights

Services

Pro Bono

Am Law 100 firm with practices in Business, Digital Assets and Data Management, Intellectual Property, Labor & Employment, Litigation and Tax.

Home | BakerHostetler

Partners discuss FTC rulemaking, litigation at direct selling seminar

Ohio Clock

Hallway with a grandfather clock displayed

The Weekly Hill Update

PDMI Take 20: AI Series, Ep. 2 — Regulatory Implications

Artificial Intelligence

Blockchain Monitor

Crypto Products Launch for Custody, Tokenization, Staking; Crypto Adoption Report Published; DFS Proposes New VC Guidance; NFT Initiatives Announced

Partner Carl Hittinger was quoted in an April 4, 2023, article in the Daily Journal titled “FTC Blocks Illumina’s purchase of cancer biotech.” The piece focused on the Federal Trade Commission’s opposition to the purchase of Grail, Inc. by the San Diego biotechnology company Illumina Inc.  Hittinger told the publication that it is premature to draw too many conclusions from the decision because there have been so few cases challenging vertical mergers.  <a href="https://www.dailyjournal.com/articles/371959" target="_blank" rel="noopener">Read the article (subscription required).</a>

Carl Hittinger Comments on FTC’s Effort to Block Purchase of Biotech Firm

Featured Insights

Related Services

Featured Insights